Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Arranz-Hernández
L. Arranz-Hernández
Medicine
Internal medicine
Diabetes mellitus
Inflammatory bowel disease
Liver cancer
3
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in spain
2021
United European gastroenterology journal
A. Hernandez Camba
L. Ramos López
M.B. Madrid Álvarez
L. Pérez Méndez
P Nos Mateu
V. Hernández Ramírez
Iván Guerra
Nelson Jiménez
R. Lorente Poyatos
M Sierra
D. Ginard Vicens
P. Varela-Trastoy
L. Arranz-Hernández
M. J. Cabello Tapia
Y. Zabana
M. Barreiro de Acosta
Show All
Source
Cite
Save
Citations (0)
P629 Efficacy, safety and economic impact of the switch to biosimilar of infliximab in inflammatory bowel disease patients in clinical practice: results of one year
2017
Journal of Crohns & Colitis
G.E. Rodríguez Glez
L. Díaz Hernández
J.A. Morales Barrios
M. Vela González
Ca Tardillo Marín
Mm Viña Romero
C.Y. Rodríguez Díaz
L. Arranz-Hernández
A. Hernandez Camba
Fj Merino Alonso
F. Perez-Hernandez
Show All
Source
Cite
Save
Citations (7)
646 APPLICABILITY OF THE BARCELONA CLINIC LIVER CANCER (BCLC) THERAPEUTIC STRATEGY AND IMPACT ON SURVIVAL IN A SINGLE TERCIARY CENTRE
2013
Journal of Hepatology
Manuel Hernández-Guerra
A. Hernandez-Camba
L. Arranz-Hernández
Alejandro Jiménez Sosa
J. Adolfo Ortega
Noemi Hernández-Álvarez
S. Pitti
F. Díaz
E. Quintero-Carrión
Show All
Source
Cite
Save
Citations (0)
1